Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Pediatric Pharmacokinetics And Safety Study Of Moxidectin

Phase 2

Withdrawn

Conditions: Onchocerciasis

Interventions: Drug: moxidectin

First Posted Date: 2009-12-21

Last Posted Date: 2012-03-29

Lead Sponsor: Pfizer

Registration Number: NCT01035619

Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection

Phase 3

Terminated

Conditions: Infection

Interventions: Drug: Ibuprofen
Drug: Placebo

First Posted Date: 2009-12-18

Last Posted Date: 2012-08-21

Lead Sponsor: Pfizer

Target Recruit Count: 16

Registration Number: NCT01035346

Locations: 🇺🇸
Pfizer Investigational Site, Salt Lake City, Utah, United States

Cost Effectiveness Of Sunitinib In Central America And Caribbean

Terminated

Conditions: Metastatic Renal Cell Carcinoma

Interventions: Drug: Sunitinib

First Posted Date: 2009-12-17

Last Posted Date: 2012-04-19

Lead Sponsor: Pfizer

Target Recruit Count: 4

Registration Number: NCT01033981

Locations: 🇵🇦
Pfizer Investigational Site, Panama City, Panama

A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers

Phase 1

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: [14C]PF00299804

First Posted Date: 2009-12-17

Last Posted Date: 2010-03-12

Lead Sponsor: Pfizer

Target Recruit Count: 6

Registration Number: NCT01034748

Locations: 🇺🇸
Pfizer Investigational Site, Tacoma, Washington, United States

A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

Phase 2

Completed

Conditions: Chronic Obstructive Airway Disease
COPD
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases

Interventions: Drug: placebo
Drug: active comparator
Drug: Low Dose PF-03635659
Drug: Mid Dose PF-03635659
Drug: High Dose PF-03635659

First Posted Date: 2009-12-16

Last Posted Date: 2016-02-19

Lead Sponsor: Pfizer

Target Recruit Count: 22

Registration Number: NCT01033487

Locations: 🇩🇪
Pfizer Investigational Site, Berlin, Germany

Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction

Completed

Conditions: Asthma
Pulmonary Disease, Chronic Obstructive

Interventions: Device: CRC-749
Device: Diskus
Device: Twisthaler
Device: Miat Monohaler

First Posted Date: 2009-12-16

Last Posted Date: 2010-03-17

Lead Sponsor: Pfizer

Target Recruit Count: 57

Registration Number: NCT01033669

Locations: 🇩🇪
Pfizer Investigational Site, Berlin, Germany

The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis

Phase 2

Completed

Conditions: Allergic Rhinitis

Interventions: Drug: PF-03654764
Drug: Placebo
Drug: Allegra-D
Drug: Allegra

First Posted Date: 2009-12-16

Last Posted Date: 2010-08-17

Lead Sponsor: Pfizer

Target Recruit Count: 64

Registration Number: NCT01033396

Locations: 🇨🇦
Pfizer Investigational Site, Kingston, Ontario, Canada

Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia

Terminated

Conditions: Community-Acquired Pneumonia

Interventions: Drug: Azithromycin SR
Drug: Amoxiclav

First Posted Date: 2009-12-15

Last Posted Date: 2011-12-21

Lead Sponsor: Pfizer

Target Recruit Count: 30

Registration Number: NCT01032694

Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis

Completed

Conditions: Maxillary Sinusitis

Interventions: Drug: Amoxiclav 1000 mg
Drug: Azithromycin SR

First Posted Date: 2009-12-15

Last Posted Date: 2012-04-16

Lead Sponsor: Pfizer

Target Recruit Count: 123

Registration Number: NCT01032174

Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected

Phase 1

Completed

Conditions: Osteoarthritis Pain
Chronic Low Back Pain
Pain Due to Interstitial Cystitis

Interventions: Other: placebo
Biological: tanezumab

First Posted Date: 2009-12-11

Last Posted Date: 2011-04-26

Lead Sponsor: Pfizer

Target Recruit Count: 28

Registration Number: NCT01030640

Locations: 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy